Obalon Therapeutics, Inc. (OBLN) |
| 3.05 -0.19 (-5.86%) 06-16 00:00 |
| Open: | 3.25 |
| High: | 4.8 |
| Low: | 2.948 |
| Volume: | 26,469,075 |
| Market Cap: | 5(M) |
| PE Ratio: | -2.22 |
| Exchange: | NASDAQ Global Market |
| Industry: | Medical - Devices |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 31.94 |
| Resistance 1: | 27.35 |
| Pivot price: | 24.77 |
| Support 1: | 22.63 |
| Support 2: | 19.71 |
| 52w High: | 32.31003 |
| 52w Low: | 1.980001 |
Obalon Therapeutics, Inc., a vertically integrated medical device company, focuses on developing and commercializing medical devices to treat people with obesity. The company offers the Obalon Balloon System designed to provide weight loss in patients with obesity. Its Obalon Balloon System comprises of a swallow able capsule that contains an inflatable balloon attached to a microcatheter; the Obalon Navigation System console, which is a combination of hardware and software used to track and display the location of the balloon during placement; the Obalon Touch Inflation Dispenser, which is a semi-automated, hand-held inflation device used to inflate the balloon once it is placed; and a disposable canister filled with mixture of gas. As of February 27, 2020, it had three company-managed retail treatment centers in California. Obalon Therapeutics, Inc. was founded in 2008 and is headquartered in Carlsbad, California.
| EPS | -0.370 |
| Book Value | 16.690 |
| PEG Ratio | 0.00 |
| Gross Profit | 4.415 |
| Profit Margin (%) | -0.63 |
| Operating Margin (%) | -3.44 |
| Return on Assets (ttm) | 1.1 |
| Return on Equity (ttm) | -2.2 |
Tue, 19 Aug 2025
Synchron Expands Executive Team with Appointment of Andy Rasdal as Chief of Staff and Mark Brister as VP R&D - Business Wire
Thu, 07 Aug 2025
ReShape Lifesciences Announces Shareholder Approval of Merger with Vyome Therapeutics - Business Wire
Mon, 02 Dec 2024
ReShape Lifesciences faces Nasdaq delisting over equity shortfall - Investing.com
Mon, 22 Jul 2024
Elucid names Kelly Huang as company president, CEO - AuntMinnie
Tue, 12 Dec 2023
Alimera Sciences Appoints Todd Wood as President of U.S. - GlobeNewswire
Fri, 01 Dec 2023
ReShape and Obalon Merge in All-Stock Transaction - Medical Device and Diagnostic industry
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |